Survival analysis suggested that the OS of colorectal cancer patients in the low AIM2 group was significantly lower than that in the high expression group (Figure 5C, P=0.036), which was consistent with our analysis and previous reports (29–32). The gene discussed is AIM2; the disease is colorectal cancer.